MTGpwn
Ludevic, Necrogenius (The List Reprints #233)

Ludevic, Necrogenius #233

The List Reprints · Legendary Creature — Human Wizard // Legendary Creature — Zombie · Rare · 2/4/3/4 P/T

Market prices

$0.20 market 0.0% 7d · updated Oct 30

PrintingLowMarketMedian
Normal$0.09$0.20$0.35

Price history

+$0.01 (+5.3%) over 31 days · High $0.21 · Low $0.15

Ludevic, Necrogenius market price, Sep 4 to Oct 30$0.21$0.18$0.15Sep 4Sep 19Oct 30
Daily prices (31 days)
DayMarketLowMedian
2026-10-30$0.20$0.09$0.35
2026-10-28$0.20$0.09$0.40
2026-10-26$0.20$0.09$0.39
2026-10-14$0.20$0.02$0.31
2026-10-11$0.20$0.02$0.34
2026-10-07$0.20$0.02$0.39
2026-10-02$0.20$0.02$0.35
2026-09-27$0.20$0.10$0.38
2026-09-26$0.20$0.10$0.35
2026-09-25$0.20$0.10$0.35
2026-09-24$0.20$0.10$0.34
2026-09-23$0.20$0.10$0.34
2026-09-22$0.21$0.10$0.33
2026-09-21$0.21$0.10$0.33
2026-09-20$0.15$0.10$0.34
2026-09-19$0.15$0.10$0.34
2026-09-18$0.15$0.10$0.35
2026-09-17$0.15$0.10$0.36
2026-09-16$0.15$0.10$0.39
2026-09-15$0.15$0.05$0.35
2026-09-14$0.15$0.05$0.35
2026-09-13$0.15$0.05$0.35
2026-09-12$0.15$0.05$0.39
2026-09-11$0.19$0.05$0.37
2026-09-10$0.19$0.05$0.37
2026-09-09$0.19$0.05$0.39
2026-09-08$0.19$0.05$0.37
2026-09-07$0.19$0.05$0.37
2026-09-06$0.19$0.05$0.35
2026-09-05$0.19$0.05$0.35
2026-09-04$0.19$0.05$0.35

Details

Type
Legendary Creature — Human Wizard // Legendary Creature — Zombie
Mana value
2
Power/Toughness
2/4/3/4
Colour
Black, Blue
Rules text
Whenever Ludevic, Necrogenius enters the battlefield or attacks, mill a card. XUUBB, Exile X creature cards from your graveyard: Transform Ludevic. X can't be 0. Activate only as a sorcery. // Olag, Ludevic's Hubris As this creature transforms into Olag, Ludevic's Hubris, it comes a copy of a creature card exiled with it, except its name is Olag, Ludevic's Hubris, it's a 4/4, and it's a legendary blue and black Zombie in addition to its other colors and types. Put a number of +1/+1 counters on Olag equal to the number of creature cards exiled with it.
Set
The List Reprints, released 2020-09-25
Card ID
40137

Comments

Sign in to join the conversation.

Loading comments…